China SXT Pharmaceuticals Inc
SXTC2.490USD
-0.510-17.00%
交易中 （美东）报价延迟15分钟
1.93M总市值
亏损市盈率 TTM
关于 China SXT Pharmaceuticals Inc 公司
China SXT Pharmaceuticals Inc is a holding company principally engaged in the research, development, manufacture, marketing and sales of Traditional Chinese Medicine Pieces (TCMP). TCMP is a type of Chinese Traditional Medicine (TCM) products. The Company sells three types of TCMP products: Advanced TCMP, Fine TCMP and Regular TCMP. The Company sells its products under the brand Suxuantang. The Company mainly operates its businesses in the domestic market.
China SXT Pharmaceuticals Inc简介
公司代码SXTC
公司名称China SXT Pharmaceuticals Inc
上市日期Jan 04, 2019
CEOBeng (Lim Sze)
员工数量75
证券类型Ordinary Share
年结日Jan 04
公司地址178 Taidong Road North
城市TAIZHOU
上市交易所NASDAQ OMX - NASDAQ BASIC
国家China
邮编225300
电话8652386298290
网址https://www.sxtchina.com/
公司代码SXTC
上市日期Jan 04, 2019
CEOBeng (Lim Sze)
China SXT Pharmaceuticals Inc公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Feng Zhou
Mr. Feng Zhou
Co-Chief Executive Officer, Director
Co-Chief Executive Officer, Director
4.00
-57.00%
Mr. Jun Zheng
Mr. Jun Zheng
Director
Director
--
--
Mr. Xiaodong Ji
Mr. Xiaodong Ji
Independent Director
Independent Director
--
--
Mr. Xiaodong Pan
Mr. Xiaodong Pan
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Tong Liu
Mr. Tong Liu
Independent Director
Independent Director
--
--
Mr. Lip Chee Yong
Mr. Lip Chee Yong
Independent Director
Independent Director
--
--
Mr. Lim Sze (Simon) Beng
Mr. Lim Sze (Simon) Beng
Co-Chief Executive Officer
Co-Chief Executive Officer
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Feng Zhou
Mr. Feng Zhou
Co-Chief Executive Officer, Director
Co-Chief Executive Officer, Director
4.00
-57.00%
Mr. Jun Zheng
Mr. Jun Zheng
Director
Director
--
--
Mr. Xiaodong Ji
Mr. Xiaodong Ji
Independent Director
Independent Director
--
--
Mr. Xiaodong Pan
Mr. Xiaodong Pan
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Tong Liu
Mr. Tong Liu
Independent Director
Independent Director
--
--
Mr. Lip Chee Yong
Mr. Lip Chee Yong
Independent Director
Independent Director
--
--
收入明细
单位: USD更新时间: 1月6日 周二
单位: USD更新时间: 1月6日 周二
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Regular TCMP
1.44M
82.86%
Advanced TCMP
258.42K
14.84%
Others
40.02K
2.30%
地区USD
名称
营收
占比
People's Republic of China
1.74M
100.00%
业务
地区
业务USD
名称
营收
占比
Regular TCMP
1.44M
82.86%
Advanced TCMP
258.42K
14.84%
Others
40.02K
2.30%
股东统计
更新时间: 1月2日 周五
更新时间: 1月2日 周五
持股股东
股东类型
持股股东
持股股东
占比
Foong Soon Hong (Randy)
7.37%
Seng (Tan Soo)
7.23%
Tan (Cheng Guan)
7.10%
Ching (Choon Hwa)
6.82%
Invesco Capital Management LLC
0.06%
其他
71.42%
持股股东
持股股东
占比
Foong Soon Hong (Randy)
7.37%
Seng (Tan Soo)
7.23%
Tan (Cheng Guan)
7.10%
Ching (Choon Hwa)
6.82%
Invesco Capital Management LLC
0.06%
其他
71.42%
股东类型
持股股东
占比
Individual Investor
28.52%
Investment Advisor
0.08%
Hedge Fund
0.08%
Investment Advisor/Hedge Fund
0.04%
Research Firm
0.02%
其他
71.26%
机构持股
更新时间: 1月1日 周四
更新时间: 1月1日 周四
报告期
机构数
持股数
持股占比
持股变动
2025Q4
18
2.07K
0.22%
+1.90K
2025Q3
18
220.19K
0.19%
+206.13K
2025Q2
20
28.22K
2.38%
-47.81K
2025Q1
20
28.22K
0.02%
-47.80K
2024Q4
22
74.93K
15.02%
+42.94K
2024Q3
24
33.98K
13.64%
+10.51K
2024Q2
21
35.50K
15.27%
+22.93K
2024Q1
24
15.92K
23.88%
+2.99K
2023Q4
23
15.02K
23.00%
+2.57K
2023Q3
23
16.29K
24.79%
+5.61K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Foong Soon Hong (Randy)
10.59M
9.13%
+10.59M
--
Jul 29, 2025
Seng (Tan Soo)
10.39M
8.96%
+10.39M
--
Jul 29, 2025
Tan (Cheng Guan)
10.20M
8.79%
+10.20M
--
Jul 29, 2025
Ching (Choon Hwa)
9.80M
8.45%
+9.80M
--
Jul 29, 2025
Invesco Capital Management LLC
89.66K
0.08%
+89.66K
--
Sep 30, 2025
Geode Capital Management, L.L.C.
53.67K
0.05%
+53.67K
--
Sep 30, 2025
Citadel Advisors LLC
48.76K
0.04%
+48.76K
--
Sep 30, 2025
Renaissance Technologies LLC
44.50K
0.04%
+44.50K
--
Sep 30, 2025
Virtu Americas LLC
28.98K
0.03%
+15.01K
+107.47%
Sep 30, 2025
HRT Financial LP
26.75K
0.02%
+26.75K
--
Sep 30, 2025
查看更多
持股ETF
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
Invesco Golden Dragon China ETF
0.08%
Invesco Golden Dragon China ETF
占比0.08%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
除权除息日
类型
比率
Jan 30, 2026
Merger
150→1
Feb 21, 2025
Merger
8→1
Feb 21, 2025
Merger
8→1
Feb 21, 2025
Merger
8→1
Feb 21, 2025
Merger
8→1
Oct 04, 2023
Merger
25→1
公告日期
除权除息日
类型
比率
Jan 30, 2026
Merger
150→1
Feb 21, 2025
Merger
8→1
Feb 21, 2025
Merger
8→1
Feb 21, 2025
Merger
8→1
Feb 21, 2025
Merger
8→1
Oct 04, 2023
Merger
25→1
Oct 04, 2023
Merger
25→1
Oct 04, 2023
Merger
25→1
Oct 04, 2023
Merger
25→1
May 18, 2022
Merger
20→1
查看更多
